Invasive infections caused by Saprochaete capitata in patients with haematological malignancies: Report of five cases and review of the antifungal therapy

Revista Iberoamericana de Micologia

Volumn 30, Issue 4, 2013, Pages 248-255

  García Ruiz, Juan Carlos ^a   López Soria, Leyre ^b   Olazábal, Iñigo ^a   Amutio, Elena ^a   Arrieta Aguirre, Inés ^c   Velasco Benito, Verónica ^b   Pontón, Jose ^c   Moragues, Maria Dolores ^c  

^a BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Antifungals; Blastoschizomyces capitatus; Geotrichum capitatum; Haematological malignancies; Molecular diagnostics; Saprochaete capitata

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AMSACRINE; ANTINEOPLASTIC AGENT; CASPOFUNGIN; CEFTAZIDIME; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FLUCONAZOLE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; IFOSFAMIDE; LEVOFLOXACIN; MEROPENEM; METHOTREXATE; MITOXANTRONE; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; PREDNISONE; RASBURICASE; RITUXIMAB; VANCOMYCIN; VORICONAZOLE;

ABDOMINAL PAIN; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FEVER; HUMAN; LUNG INFILTRATE; MACULOPAPULAR RASH; MALE; MOUTH ULCER; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; NEUTROPENIA; PANCOLITIS; PLEURA EFFUSION; RESPIRATORY FAILURE; SAPROCHAETE CAPITATA INFECTION; SYSTEMIC MYCOSIS; THORAX RADIOGRAPHY;

CANDIDA; CAPITATA; DIPODASCUS CAPITATUS; FUNGI; TILLANDSIA;

ANTIFUNGALS; ANTIMICÓTICOS; BLASTOSCHIZOMYCES CAPITATUS; CÁNCER HEMATOLÓGICO; DIAGNÓSTICO MOLECULAR; GEOTRICHUM CAPITATUM; HAEMATOLOGICAL MALIGNANCIES; MOLECULAR DIAGNOSTICS; SAPROCHAETE CAPITATA;

ADULT; AGED; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CATHETER-RELATED INFECTIONS; CROSS INFECTION; DIPODASCUS; DRUG RESISTANCE, FUNGAL; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEBRILE NEUTROPENIA; FEMALE; FUNGEMIA; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS;

EID: 84887613765     PISSN: 11301406     EISSN: 21739188     Source Type: Journal    
DOI: 10.1016/j.riam.2013.02.004     Document Type: Article

References (63)

1. Adami F., Scarin M., Pescarini L., Binotto G., Pavan L., Sgarabotto D., et al. Successful control of Blastoschizomyces capitatus infection in three consecutive acute leukaemia patients despite initial unresponsiveness to liposomal amphotericin B. Mycoses 2011, 54:365-369.
2. Amft N., Miadonna A., Viviani M.A., Tedeschi A. Disseminated Geotrichum capitatum infection with predominant liver involvement in a patient with non Hodgkin's lymphoma. Haematologica 1996, 81:352-355.
3. Batlle M., Quesada M.D., Moreno M., Ribera J.M. Outbreak of Blastoschizomyces spp. infection in a haematology unit: study of 6 cases and finding of the source of infection. Med Clin (Barc) 2010, 135:672-674.
4. Bonini A., Capatti C., Parmeggiani M., Gugliotta L., Micozzi A., Gentile G., et al. Galactomannan detection in Geotrichum capitatum invasive infections: report of 2 new cases and review of diagnostic options. Diagn Microbiol Infect Dis 2008, 62:450-452.
5. Bouakline A., Lacroix C., Roux N., Gangneux J.P., Derouin F. Fungal contamination of food in hematology units. J Clin Microbiol 2000, 38:4272-4273.
6. Bouza E., Muñoz P. Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp. Clin Microbiol Infect 2004, 10(Suppl. 1):76-85.
7. Buchta V., Zak P., Kohout A., Otcenasek M. Case report. Disseminated infection of Blastoschizomyces capitatus in a patient with acute myelocytic leukaemia. Mycoses 2001, 44:505-512.
8. Chamilos G., Luna M., Lewis R.E., Bodey G.P., Chemaly R., Tarrand J.J., et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006, 91:986-989.
9. Chang W.W., Buerger L. Disseminated geotrichosis: case report. Arch Intern Med 1964, 113:356-360.
10. Chittick P., Palavecino E.L., Delashmitt B., Evans J., Peacock J.E. Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy. Antimicrob Agents Chemother 2009, 53:5306-5307.
11. Christakis G., Perlorentzou S., Aslanidou M., Megalakaki A., Velegraki A. Fatal Blastoschizomyces capitatus sepsis in a neutropenic patient with acute myeloid leukemia: first documented case from Greece. Mycoses 2005, 48:216-220.
12. M27-A3. Reference method for broth dilution antifungal susceptibility testing of yeast 2008, Clinical, Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA. 3rd ed.
13. Cuenca-Estrella M., Gomez-Lopez A., Mellado E., Buitrago M.J., Monzon A., Rodriguez-Tudela J.L. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother 2006, 50:917-921.
14. Cuétara M.S., Alhambra A., Moragues M.D., González-Elorza E., Pontón J., del Palacio A. Detection of (1→3)-beta-d-glucan as an adjunct to diagnosis in a mixed population with uncommon proven invasive fungal diseases or with an unusual clinical presentation. Clin Vaccine Immunol 2009, 16:423-426.
15. Dannaoui E., Lortholary O., Raoux D., Bougnoux M.E., Galeazzi G., Lawrence C., et al. Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006. Antimicrob Agents Chemother 2008, 52:778-781.
16. D'Antonio D., Mazzoni A., Iacone A., Violante B., Capuani M.A., Schioppa F., et al. Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients. J Clin Microbiol 1996, 34:753-755.
17. D'Antonio D., Parruti G., Pontieri E., Di Bonaventura G., Manzoli L., Sferra R., et al. Slime production by clinical isolates of Blastoschizomyces capitatus from patients with hematological malignancies and catheter-related fungemia. Eur J Clin Microbiol Infect Dis 2004, 23:787-789.
18. D'Antonio D., Piccolomini R., Fioritoni G., Iacone A., Betti S., Fazii P., et al. Osteomyelitis and intervertebral discitis caused by Blastoschizomyces capitatus in a patient with acute leukemia. J Clin Microbiol 1994, 32:224-227.
19. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
20. DeMaio J., Colman L. The use of adjuvant interferon-gamma therapy for hepatosplenic Blastoschizomyces capitatus infection in a patient with leukemia. Clin Infect Dis 2000, 31:822-824.
21. Ersoz G., Otag F., Erturan Z., Aslan G., Kaya A., Emekdas G., et al. An outbreak of Dipodascus capitatus infection in the ICU: three case reports and review of the literature. Jpn J Infect Dis 2004, 57:248-252.
22. Etienne A., Datry A., Gaspar N., Morel V., Delabesse E., Lmimouni B., et al. Successful treatment of disseminated Geotrichum capitatum infection with a combination of caspofungin and voriconazole in an immunocompromised patient. Mycoses 2008, 51:270-272.
23. Fianchi L., Montini L., Caira M., Voso M.T., Maviglia R., Posteraro B., et al. Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient. Infection 2008, 36:65-67.
24. Fouassier M., Joly D., Cambon M., Peigue-Lafeuille H., Condat P. Geotrichum capitatum infection in a neutropenic patient. Apropos of a case and review of the literature. Rev Med Interne 1998, 19:431-433.
25. Gadea I., Cuenca-Estrella M., Prieto E., Diaz-Guerra T.M., Garcia-Cia J.I., Mellado E., et al. Genotyping and antifungal susceptibility profile of Dipodascus capitatus isolates causing disseminated infection in seven hematological patients of a tertiary hospital. J Clin Microbiol 2004, 42:1832-1836.
26. Giacchino M., Chiapello N., Bezzio S., Fagioli F., Saracco P., Alfarano A., et al. Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum. J Clin Microbiol 2006, 44:3432-3434.
27. Girmenia C., Micozzi A., Venditti M., Meloni G., Iori A.P., Bastianello S., et al. Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient. Eur J Clin Microbiol Infect Dis 1991, 10:752-756.
28. Girmenia C., Pagano L., Martino B., D'Antonio D., Fanci R., Specchia G., et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005, 43:1818-1828.
29. Girmenia C., Pizzarelli G., D'Antonio D., Cristini F., Martino P. In vitro susceptibility testing of Geotrichum capitatum: comparison of the E-test, disk diffusion, and Sensititre colorimetric methods with the NCCLS M27-A2 broth microdilution reference method. Antimicrob Agents Chemother 2003, 47:3985-3988.
30. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998, 92:2322-2333.
31. Guinea J., Recio S., Escribano P., Pelaez T., Gama B., Bouza E. In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens. Antimicrob Agents Chemother 2010, 54:4012-4015.
32. Gurgui M., Sanchez F., March F., Lopez-Contreras J., Martino R., Cotura A., et al. Nosocomial outbreak of Blastoschizomyces capitatus associated with contaminated milk in a haematological unit. J Hosp Infect 2011, 78:274-278.
33. Hachem R., Hanna H., Kontoyiannis D., Jiang Y., Raad I. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 2008, 112:2493-2499.
34. Henrich T.J., Marty F.M., Milner D.A., Thorner A.R. Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature. Transpl Infect Dis 2009, 11:458-462.
35. Ikuta K., Torimoto Y., Yamamoto M., Okamura N., Hosoki T., Sato K., et al. Successful treatment of systemic Geotrichum capitatum infection by liposomal amphotericin-B, itraconazole, and voriconazole in a Japanese man. Intern Med 2010, 49:2499-2503.
36. Jain P., Khan Z.K., Bhattacharya E., Ranade S.A. Variation in random amplified polymorphic DNA (RAPD) profiles specific to fluconazole-resistant and -sensitive strains of Candida albicans. Diagn Microbiol Infect Dis 2001, 41:113-119.
37. Kassamali H., Anaissie E., Ro J., Rolston K., Kantarjian H., Fainstein V., et al. Disseminated Geotrichum candidum infection. J Clin Microbiol 1987, 25:1782-1783.
38. Lortholary O., Desnos-Ollivier M., Sitbon K., Fontanet A., Bretagne S., Dromer F., et al. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother 2011, 55:532-538.
39. Martino P., Venditti M., Micozzi A., Morace G., Polonelli L., Mantovani M.P., et al. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis 1990, 12:570-582.
40. Martino R., Salavert M., Parody R., Tomás J.F., de la Cámara R., Vázquez L., et al. Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases. Clin Infect Dis 2004, 38:335-341.
41. Mejdoubi M., Huynh A., Danho C., Boot B. Cervical spondylodiscitis caused by Blastoschizomyces capitatus. Infection 2009, 37:153-155.
42. Morace G., Polonelli L. Voriconazole activity against clinical yeast isolates: a multicentre Italian study. Int. J. Antimicrob. Agents 2005, 26:247-253. GISIA Group.
43. Neofytos D., Horn D., Anaissie E., Steinbach W., Olyaei A., Fishman J., et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin. Infect. Dis. 2009, 48:265-273.
44. Pagano L., Caira M., Candoni A., Offidani M., Fianchi L., Martino B., et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006, 91:1068-1075.
45. Pagano L., Caira M., Nosari A., Van Lint M.T., Candoni A., Offidani M., et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin. Infect. Dis. 2007, 45:1161-1170.
46. Park B.J., Arthington-Skaggs B.A., Hajjeh R.A., Iqbal N., Ciblak M.A., Lee-Yang W., et al. Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. Antimicrob. Agents Chemother. 2006, 50:1287-1292.
47. Paz I., Barbeyto L., Tinajas A., Sastre J.L., Rodriguez-Tudela J.L. Blastoschizomyces capitatus fungemia in a neutropenic patient. Enferm. Infecc. Microbiol. Clin. 2000, 18:291-292.
48. Pérez-Sanchez I., Anguita J., Martín-Rabadan P., Muñoz P., Serrano D., Escudero A., et al. Blastoschizomyces capitatus infection in acute leukemia patients. Leuk. Lymphoma 2000, 39:209-212.
49. Pfaller M.A., Diekema D.J. Epidemiology of invasive mycoses in North America. Crit. Rev. Microbiol. 2010, 36:1-53.
50. Pfaller M.A., Diekema D.J., Andes D., Arendrup M.C., Brown S.D., Lockhart S.R., et al. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist. Updat. 2011, 14:164-176.
51. Polacheck I., Salkin I.F., Kitzes-Cohen R., Raz R. Endocarditis caused by Blastoschizomyces capitatus and taxonomic review of the genus. J. Clin. Microbiol. 1992, 30:2318-2322.
52. Quindós G., García-Ruiz J.C., Sanz M.A. Otras infecciones fúngicas invasoras. Micosis invasoras en pacientes oncohematológicos 2009, Revista Iberoamericana de Micología ed, Bilbao, España, p. 79-95.
53. Richardson M., Lass-Florl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 2008, 14(Suppl. 4):5-24.
54. Romano A., Giordano S., Di Carlo P., Abbagnato L., Sapuppo F., Lazzaro G., et al. Pulmonary infection caused by Blastoschizomices capitatus. Infez Med 2005, 13:187-191.
55. Salonen J.H., Richardson M.D., Gallacher K., Issakainen J., Helenius H., Lehtonen O.P., et al. Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae. J. Hosp. Infect. 2000, 45:293-301.
56. Sancak B., Alp S., Hascelik G., Arikan S. Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods. Mikrobiyol. Bul. 2009, 43:269-276.
57. Sanz M.A., Lopez F., Martinez M.L., Sanz G.F., Martinez J.A., Martin G., et al. Disseminated Blastoschizomyces capitatus infection in acute myeloblastic leukaemia. Report of three cases. Support. Care Cancer 1996, 4:291-293.
58. Savini V., Catavitello C., Balbinot A., Masciarelli G., Astolfi D., Pompilio A., et al. Multidrug-resistant Geotrichum capitatum from a haematology ward. Mycoses 2011, 54:542-543.
59. Schuermans C., van Bergen M., Coorevits L., Verhaegen J., Lagrou K., Surmont I., et al. Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature. Med Mycol 2011, 49:414-418.
60. Slovak M.L., Kopecky K.J., Cassileth P.A., Harrington D.H., Theil K.S., Mohamed A., et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000, 96:4075-4083.
61. Viscoli C., Girmenia C., Marinus A., Collette L., Martino P., Vandercam B., et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999, 28:1071-1079.
62. Walsh T.J., Groll A., Hiemenz J., Fleming R., Roilides E., Anaissie E. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004, 10(Suppl. 1):48-66.
63. White T.J., Bruns T.D., Lee S.B., Taylor J.W. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR protocols. A guide to methods and applications 1990, 315-322. Academic Press, San Diego, CA. M.A. Innis, D.H. Gelfand, J.J. Sninsky, T.J. White (Eds.).